Post Market Clinical Follow Up Study of Avance Foam Abdominal Dressing Kit in Open Abdomen
- Conditions
- Open Abdomen
- Interventions
- Device: Avance Foam dressing kit
- Registration Number
- NCT01968811
- Lead Sponsor
- Molnlycke Health Care AB
- Brief Summary
The investigation is a Post Marketing Follow-Up Study for the Avance Foam Abdominal Dressing Kit conducted as part of Mölnlycke Health Care's quality system. The primary objective is to evaluate the dressing kit as part of a negative pressure system. The secondary objectives are to collect and evaluate safety data, performance data and information on technical complications.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
- Provision of written informed consent from subject or family member
- Subjects with open abdomen suitable for temporary closure with NPWT therapy
- Subjects where the viscera and/or abdominal organs need to be protected by an abdominal organ contact layer (OCL)
- Subject which (at the time of the baseline visit) are planned to be cared for between dressing changes at Intensive Care Unit
- Male or female, 18 years and above
- Synthetic mesh inserted in the abdomen
- Non-enteric fistulae or unexplored fistulas
- Untreated osteomyelitis
- Malignant wounds
- Abdominal wall hernia
- Subjects previously treated with an NPWT abdominal dressing
- Known allergy or hypersensitivity to any of the components in the dressing
- Pregnancy
- Subjects not suitable for the investigation according to the investigator's judgement
- Subjects included in other ongoing clinical investigation at present which could interfere with this investigation, as judged by the investigator
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Avance foam, abdominal dressing kit Avance Foam dressing kit -
- Primary Outcome Measures
Name Time Method To Evaluate the Performance of the Dressing Kit as Part of a Negative Pressure System in Post Market Clinical Follow-up Settings From 1 to 3 visit, depending on each subject/wound, up to 4 days. Outcome of each subject was evaluated and presented individually. Questionnaires answered by surgeon at application and removal of the kit; Baseline Overall ease of application of the kit: No. of surgeons rated as; Very easy= 4/Easy=3/Somewhat easy=2/Not easy Overall satisfaction with the kit:No. of surgeons rated as Very satisfied=3/ Satisfied=5/ Unsatisfied=2/ Very unsatisfied=0
Questionnaires were answered by surgeon at application and removal of the kit; Visit 2 Overall ease of application of the kit:No.of surgeons rated as Very easy= 2/Easy=5/Somewhat easy=0/Not easy=1 Overall satisfaction with the kit: No.of surgeons rated as Very satisfied=1/ Satisfied=3/ Unsatisfied=4/ Very unsatisfied=0 Visit 3 Overall ease of application of the kit: No.of surgeons rated as Very easy= 0/Easy=6/Somewhat easy=0/Not easy=0 Overall satisfaction. No of surgeons rated as Very satisfied=0, satisfied=4, unsatisfied=2, very unsatisfied=0
- Secondary Outcome Measures
Name Time Method - Fascial/Skin Closure of the Open Abdomen End of treatment, up to 4 days. The performance objective is assessed through general application and removal questions after each investigational device handling.
Trial Locations
- Locations (1)
Sahlgrenska University hospital
🇸🇪Göteborg, Sweden